Litcius/Paper detail

Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Renata Ferrarotto, Priyadharsini Nagarajan, Jacob M. Maronge, Jason M. Johnson, David I. Rosenthal, Jeffrey N. Myers, Neil D. Gross

2023JAMA Otolaryngology–Head & Neck Surgery20 citationsDOIOpen Access PDF

Abstract

This secondary analysis of a phase 2 clinical trial examines long-term survival for resectable cutaneous squamous cell carcinoma of the head and neck according to pathologic response.

Topics & Concepts

Head and neckMedicineBasal cellOncologyInternal medicineSurgeryNonmelanoma Skin Cancer StudiesInfectious Diseases and MycologyHead and Neck Cancer Studies
Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Litcius